• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·France·Healthcare·ALDMS.PA
Share

Diagnostic Medical Systems S.A. Stocks

€ 1.02Last Updated 04.09.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

€ 30.74M

€ 1.02
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Operating within the medical imaging sector, Diagnostic Medical Systems S.A. serves both French and international markets. The company provides a comprehensive suite of solutions, encompassing radiography/fluoroscopy, mammography, bone densitometry, and advanced 3D reconstruction. Its product portfolio also includes specialized retrofit kits, mobile imaging units, chest and bone room systems, and mobile C-arms. Beyond imaging, the firm offers cutting-edge technologies for the treatment of osteoarthritis and regenerative medicine through fat stem cell injections. Founded in 1979, Diagnostic Medical Systems S.A. is headquartered in Mauguio, France.

Company Valuation

Slightly undervalued
5/7

Considering past and projected metrics, the stock is 'cheaper' than its peers. In particular, the stock is reasonably priced on P/E, 'cheap' on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

05.09.2026 23:47

The U.S. struck three Iranian oil tankers in response to an attack on its aircraft carrier

05.09.2026 16:01

Small-Cap Highlights: Betting on Marc Jacobs, GoPro's Outlook, the Dropbox Hack

05.09.2026 13:01

Oil is nearing $100, the Fed is easing market jitters, and Nvidia is acquiring Hugging Face

05.09.2026 03:39

It lacked drama: Analysts explain Tesla's stock plunge following the launch of the Cybercab

05.09.2026 03:09

Three companies will be added to the S&P 500 in September. Which companies were removed from the index?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026